Antidepressant Approvals Could Herald New Era in Psychiatric Drugs

From The Scientist, 1 October 2019: As droughts go, the one plaguing the antidepressant drug development landscape for the past few decades has been noteworthy. Since the advent of serotonin and norepinephrine reuptake inhibitors in the 1980s and 1990s, there has been a dearth of new pharmacological therapies for mood disorders, says psychiatrist Samantha Meltzer-Brody, Continue reading Antidepressant Approvals Could Herald New Era in Psychiatric Drugs